Abstract:Longstanding compacted erythrocytes impair bone regeneration. This study employs the hypoxia‐mimetic agent DMOG to enhance macrophage‐elimination of erythrocytes by up‐regulating integrin αvβ3. Increased phagocytosed erythrocytes regulate macrophage intracellular Fe2+‐glycolysis‐inflammation, creating a favorable bone regenerative microenvironment characterized by loose fibrin meshes with down‐regulated inflammatory responses in vivo. These findings pave the way for advanced biomaterial development focusing on the bio‐elimination of erythrocytes. Erythrocytes are the dominant component of a blood clot in terms of volume and number. However, longstanding compacted erythrocytes in blood clots form a physical barrier and make fibrin mesh more anti‐fibrinolytic, thus impeding infiltration of mesenchymal stem cells. The necrosis or lysis of erythrocytes that are not removed timely can also lead to the release of pro‐inflammatory toxic metabolites, interfering with bone regeneration. Proper bio‐elimination of erythrocytes is essential for an undisturbed bone regeneration process. Here, hypoxia‐mimicking is applied to enhance macrophage‐elimination of erythrocytes. The effect of macrophage‐elimination of erythrocytes on the macrophage intracellular reaction, bone regenerative microenvironment, and bone regeneration outcome is investigated. Results show that the hypoxia‐mimicking agent dimethyloxalylglycine successfully enhances erythrophagocytosis by macrophages in a dose‐dependent manner primarily by up‐regulating the expression of integrin αvβ3. Increased phagocytosed erythrocytes then regulate macrophage intracellular Fe2+‐glycolysis‐inflammation, creating an improved bone regenerative microenvironment characterized by loose fibrin meshes with down‐regulated local inflammatory responses in vivo, thus effectively promoting early osteogenesis and ultimate bone generation. Modulating macrophage‐elimination of erythrocytes can be a promising strategy for eradicating erythrocyte‐caused bone regeneration hindrance and offers a new direction for advanced biomaterial development focusing on the bio‐elimination of erythrocytes.

Retinoids Promote Mouse Bone Marrow-Derived Macrophage Differentiation and Efferocytosis via Upregulating Bone Morphogenetic Protein-2 and Smad3

Retinol Saturase Knock-Out Mice are Characterized by Impaired Clearance of Apoptotic Cells and Develop Mild Autoimmunity

Cutting edge: Parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2

Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.

Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids

Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution

Macrophage-Derived Protein S Facilitates Apoptotic Polymorphonuclear Cell Clearance by Resolution Phase Macrophages and Supports Their Reprogramming

Resveratrol and ω-3 PUFAs Promote Human Macrophage Differentiation and Function

Extracellular Soluble Membranes from Retinal Pigment Epithelial Cells Mediate Apoptosis in Macrophages

Resolvin D1 promotes the targeting and clearance of necroptotic cells

Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution

Retinoid X Receptor Agonists Inhibit Phorbol-12-myristate-13-acetate (Pma)-Induced Differentiation of Monocytic THP-1 Cells into Macrophages.

Ex Vivo and In Vitro Effect of Serum Amyloid A in the Induction of Macrophage M2 Markers and Efferocytosis of Apoptotic Neutrophils

Resolvin E1 and chemokine-like receptor 1 mediate bone preservation

Ceramide Imbalance and Impaired TLR4-Mediated Autophagy in BMDM of an ORMDL3-Overexpressing Mouse Model

Retinoic Acid Ameliorates Rheumatoid Arthritis by Attenuating Inflammation and Modulating Macrophage Polarization Through MKP-1/MAPK Signaling Pathway

Monocytic Mdscs Skew Th17 Cells Toward A Pro-Osteoclastogenic Phenotype and Potentiate Bone Erosion in Rheumatoid Arthritis

Resveratrol and piceid enhance efferocytosis by increasing the secretion of MFG-E8 in human THP-1 macrophages

An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption

Macrophages Promote Osteoblastic Differentiation In Vivo: Implications in Fracture Repair and Bone Homeostasis

Hypoxia‐Mimicking Mediated Macrophage‐Elimination of Erythrocytes Promotes Bone Regeneration via Regulating Integrin αvβ3/Fe2+‐Glycolysis‐Inflammation